Status:
COMPLETED
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
Lead Sponsor:
Korea University Guro Hospital
Conditions:
Streptococcal Pneumonia
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
HIV-infected patients are 30- to 100-fold more susceptible to invasive pneumococcal diseases. Pneumococcal vaccination is the best way to decrease the large pneumococcal disease burden, but the optima...
Detailed Description
This single-center, open-label non-randomized clinical trial was conducted at Korea University Guro Hospital from April 2015 to January 2017. Based on the CD4 T-cell counts at the time of study enroll...
Eligibility Criteria
Inclusion
- HIV-infeted subjects who received antiretroviral therapy for ≥ 4 weeks
Exclusion
- a history of pneumococcal infection within the recent five years
- previous pneumococcal vaccination
- current opportunistic infections
- known immunodeficiency other than HIV infection
- coagulation disorders
Key Trial Info
Start Date :
April 2 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03838497
Start Date
April 2 2015
End Date
February 28 2017
Last Update
February 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.